Stay updated on Pembrolizumab Combo in Endometrial Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Endometrial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Endometrial Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The Record History page now shows the latest revision as v3.6.3, replacing v3.6.2. This change represents a metadata-level update reflecting the page's rendering version.
    Difference
    0.0%
    Check dated 2026-07-06T15:52:02.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The page shows a new site revision, updating the footer from v3.6.0 to v3.6.2. This indicates a software version update rather than modification of study data.
    Difference
    0.0%
    Check dated 2026-06-29T08:57:30.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Recruitment status updated to 'No longer looking for participants,' signaling that recruitment has closed. The revision history shows a new revision tag, v3.6.0, replacing the previous v3.5.5.
    Difference
    0.2%
    Check dated 2026-06-15T05:32:38.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    A new version of the study record (v3.5.5) was published on 2026-06-04/05, introducing the Contacts/Locations and Study Status sections. The prior revision (v3.5.4) from 2025-06-09 was removed.
    Difference
    0.3%
    Check dated 2026-06-08T03:47:12.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Footer revision label updated from v3.5.3 to v3.5.4, indicating a new release of the page assets.
    Difference
    0.0%
    Check dated 2026-05-17T09:00:08.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    The page’s displayed revision/build number has been updated from **v3.5.2** to **v3.5.3** for the ClinicalTrials.gov interface.
    Difference
    0.0%
    Check dated 2026-04-25T18:28:14.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Endometrial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Endometrial Cancer Clinical Trial page.